We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ADVERSE EVENT REPORTS TO FDA SURGE THROUGH eFILINGS
ADVERSE EVENT REPORTS TO FDA SURGE THROUGH eFILINGS
May 26, 2004
The number of adverse events reported to the FDA’s Center for Drug Evaluation and Research (CDER) increased 15 percent last year largely due to electronic filing of adverse event reports, according to the center’s chief.